EFFICACY AND SAFETY OF HIP1601 (DUAL DELAYED-RELEASE ESOMEPRAZOLE) 40MG IN EROSIVE ESOPHAGITIS COMPARED TO HGP1705 (DELAYED-RELEASE ESOMEPRAZOLE) 40MG: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, NON-INFERIORITY STUDY

Hyun Lim  ¹     Hwoon-Yong Jung  ^2    
1 University of Hallym College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea (Republic of)
² University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea (Republic of)

Session
Oesophageal, gastric and duodenal disorders (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)